Behçet's disease is a genetically complex disease of unknown etiology characterized by recurrent inflammatory attacks affecting the orogenital mucosa, eyes and skin. We performed a genome-wide association study with 311,459 SNPs in 1,215 individuals with Behçet's disease (cases) and 1,278 healthy controls from Turkey. We confirmed the known association of Behçet's disease with HLA-B*51 and identified a second, independent association within the MHC Class I region. We also identified an association at IL10 (rs1518111, P = 1.88 × 10 −8 ). Using a meta-analysis with an additional five cohorts from Turkey, the Middle East, Europe and Asia, comprising a total of 2,430 cases and 2,660 controls, we identified associations at IL10 (rs1518111, P = 3.54 × 10 −18 , odds ratio = 1.45, 95% CI 1.34-1.58) and the IL23R-IL12RB2 locus (rs924080, P = 6.69 × 10 −9 , OR = 1.28, 95% CI 1.18-1.39). The disease-associated IL10 variant (the rs1518111 A allele) was associated with diminished mRNA expression and low protein production.
l e t t e r s
The most significantly associated SNPs (P < 10 −44 ) were located on chromosome 6 in the MHC region. To evaluate the contribution of the HLA-B*51 allele to Behçet's disease, we determined the HLA-B types of 1,190 of the cases and 1,257 of the controls. Occurrence (meaning the presence of either one of two copies) of the HLA-B*51 variant was found in 59.1% of cases and 29.3% of controls (OR = 3.49, 95% CI 2.95-4.12, P = 5.47 × 10 −50 ). Within the HLA-B region, the most significantly associated SNPs were located in the area spanning from telomeric to the HLA-B coding region to centromeric to MICA (encoding MHC class I chain related sequence A), which has been suggested to be the source of the association of HLA-B*51 with Behçet's disease 6 . We found that the HLA-B*51 variant was more strongly associated with disease than was any genotyped SNP (HLA-B*51 allele frequency was 0.352 in cases and 0.159 in controls, P = 1.44 × 10 −54 ; Fig. 2 ). Strong linkage disequilibrium (LD) was observed between HLA-B*51 and all the SNPs located in the region from HLA-B to more than 62-kb centromeric to MICA, despite the fact that this region spans several blocks of LD (Supplementary Fig. 3 ). This LD pattern is observed because the HLA-B*51 variant is found almost exclusively on a single extended haplotype. This extended haplotype occurred at a frequency of 0.321 in cases and 0.144 in controls. Notably, the identical SNP haplotype lacking HLA-B*51 occurred in cases and controls equally, at a frequency of 0.04, suggesting that HLA-B*51 is required for the disease association in the HLA-B region.
We next performed a conditional logistic regression analysis of the 294 SNPs from the MHC region with allelic χ 2 P < 0.0001, specifying HLA-B*51 as a covariate. None of the HLA-B-MICA region SNPs remained significantly associated with Behçet's disease in the conditional analysis ( Fig. 2) . However, after accounting for the effect of HLA-B*51, three SNPs within the HLA-A region retained genome-wide significance. The most strongly associated SNP, rs9260997, located 50-kb centromeric to HLA-A, had a regressor P = 5.49 × 10 −9 , suggesting a highly significant association independent of the HLA-B*51 association. An association of markers within the HLA-A region independent of HLA-B*51 was recently described in Japanese Behçet's disease cases, with attribution of the association to the HLA-A*26 allele 5 .
In the association data ( Fig. 1) , we identified near genome-wide significance for one non-MHC SNP, rs936551 (P = 5.29 × 10 −8 ), located at the telomeric end of the short arm of chromosome 4 within the promoter region of CPLX1; CPLX1 encodes complexin-1, a regulator of exocytosis during vesicle membrane fusion. Additionally, one SNP located within the first intron of IL10, rs3024490, was strongly suggestive for association, with P = 2.22 × 10 −7 (Fig. 1) . We also identified an additional 66 SNPs from 49 chromosomal regions with suggestive evidence for disease association using the threshold of P < 0.0001 ( Supplementary Table 2 ).
To better evaluate genetic associations within the CPLX1 and IL10 regions, we genotyped the same case and control samples for additional SNPs from the regions predicted by HapMap CEU data to be in LD with the disease-associated SNP. We also fine-mapped the IL23R-IL12RB2 region, which was identified in an independent GWAS of Behçet's disease in a Japanese population 7 and within which we found three SNPs with P < 0.0001 (Supplementary Table 2 ).
In the CPLX1 region, the additional genotyped SNPs increased the estimated coverage (at r 2 > 0.8) of HapMap Phase II SNPs with minor allele frequency greater than 5% from 57% to 93%. The most significantly associated SNPs were located in the promoter region of the gene, although none were more significantly associated than rs936551 ( Supplementary Fig. 4 ).
In the IL10 region, we genotyped 27 additional SNPs, resulting in coverage of 100% of the HapMap Phase II SNPs with greater than 5% minor allele frequency in the CEU samples. Five SNPs were found to be strongly associated with Behçet's disease, with one SNP, rs1518111, reaching genome-wide significance (P = 1.88 × 10 −8 ; Fig. 3a) . The disease-associated SNPs were located in the promoter region and in the first, second and third introns of the gene (Supplementary Fig. 5 ), and all were in strong LD with one another.
In the IL23R-IL12RB2 region, we genotyped 11 additional SNPs, thereby increasing coverage of the HapMap Phase II SNPs with greater than 5% minor allele frequency in the CEU samples from 58% to 88%. No SNPs from the GWAS analysis were found to have a stronger association than rs924080 ( Fig. 3b) . We identified a recombination hot spot located in the intergenic region between IL23R and IL12RB2 (Fig. 3b) , which is also seen in the HapMap Figure 2 Analysis of associations within the MHC region. The 294 SNPs from the MHC region with allelic χ 2 P < 0.0001 are shown before (blue symbols) and after (red symbols) conditioning for HLA-B51 (including 1,190 cases and 1,257 controls). Blue symbols represent -log 10 P found by allelic χ 2 test. Red symbols represent -log 10 regressor P values of the same markers from a logistic regression analysis with HLA-B*51 specified as a covariate. The green horizontal line at -log 10 P = 7.301 corresponds to the genome-wide significance threshold of P = 5 × 10 −8 . The locations of HLA genes are shown above the association graph.
7 0 0 VOLUME 42 | NUMBER 8 | AUGUST 2010 Nature GeNetics l e t t e r s European-descent and Asian populations (E.F.R., data not shown). The Behçet's diseaseassociated variants were located on the IL23R side of the hot spot, suggesting the disease association is more likely to be linked to IL23R rather than IL12RB2. Variants within IL23R have been associated with ankylosing spondylitis 8 , psoriasis 9 and inflammatory bowel disease 10 , diseases having some phenotypic overlap with each other and with Behçet's disease. However, neither of the two IL23R coding variants associated with these seronegative diseases was associated with Behçet's disease ( Fig. 3b) .
We genotyped the Behçet's disease-associated IL10, IL23R-IL12RB2 and CPLX1 SNPs in five additional collections of Behçet's disease cases and controls from Turkey, the Middle East, Europe and Asia ( Table 1 and Online Methods). A surrogate marker (rs11248047) was used in the place of the CPLX1 disease-associated SNP (rs936551), which failed quality control in the replication assay ( Supplementary Fig. 4 and Table 1 ). A number of the UK European-descent and Middle Eastern Arab samples were previously tested for association of two IL10 promoter region SNPs with Behçet's disease. Although an association with disease was reported in the UK collection, the association had not replicated in the Middle Eastern Arab collection 11 . The Behçet's disease-associated IL10 SNP identified in the Turkish population, rs1518111, reached statistical significance after correction for three tests (P < 0.017) in the Middle Eastern Arab and Greek collections and was of nominal significance (P < 0.05) in the UK European descent collection ( Table 1) . For the most part, the IL23R-IL12RB2 and CPLX1 SNPs showed the same trend as found in the Turkish discovery samples; however, the associations did not reach statistical significance in these smaller collections. Association of these markers was not observed in the small Turkish replication collection. Although this lack of association could be explained by small sample size, an alternative explanation could be that the markers are associated with severe disease, as we have noted that disease manifestations in the replication collection (drawn from a dermatology clinic) were milder than in the discovery collection used for the GWAS, which was obtained from a rheumatology clinic.
We exchanged data with an independent group that had also performed a GWAS for Behçet's disease 7 for cross validation purposes. The researchers in this coordinated publication identified IL10 and the IL23R-IL12RB2 loci to be associated with Behçet's disease in a Japanese population, but they did not observe the CPLX1 association. A meta-analysis of all the association data (including a total of 2,240 Behçet's disease cases and 2,640 controls) provided strong evidence for associations of the IL10 and IL23R-IL12RB2 loci with Behçet's disease ( Table 1) . Association of the CPLX1 variant failed to replicate in any of the additional collections and failed to reach genome-wide significant association in a meta-analysis of the data. Analysis of even larger numbers of replication samples will be required to establish whether the CPLX1 locus contributes to Behçet's disease susceptibility.
Several SNP haplotypes of the IL10 gene promoter have been reported to be associated with regulation of the gene's expression, but the reported allelic effects have been inconsistent and difficult to reconcile [12] [13] [14] . We therefore tested for a difference in expression of the gene between the disease-associated haplotype and other haplotypes by measuring the allelic imbalance of the rs1518111 variant in pre-mRNA from monocytes isolated from eight healthy individuals heterozygous for the disease-associated allele. In all eight donors, the pre-mRNA transcript with the rs1518111 A allele was found at reduced levels compared to the G allele. Expression of the A-bearing chromosome was 35% that of the G-bearing chromosome (Fig. 4a) .
To assess whether this expression difference was relevant in terms of cytokine production, we activated mononuclear cells from healthy Turkish donors with lipopolysaccharide (LPS) and found significantly lower amounts of IL-10 protein in supernatants from donors homozygous for the rs1518111 A allele compared to those from individuals with one or two G alleles (Fig. 4b) . We also cultured monocytes from ethnically diverse healthy donors from the United States and stimulated the cells with two Toll-like-receptor-containing and nucleotide-binding oligomerization-domain-containing receptor ligands, the lipoprotein Pam 3 Cys, and muramyl dipeptide (MDP). Individuals homozygous for the Behçet's disease-associated rs1518111 A allele produced significantly less IL-10 than individuals with one or two G alleles (Fig. 4c) , whereas no statistically significant variation was found in TNFα production (B.Y. and M. Gadina, data not shown).
Taken together, these data suggest that genetic variants contributing to low IL-10 expression may be a risk factor for Behçet's disease. There are extensive data in mouse models linking reduction in IL-10 expression with inflammation 15 . Variants in the IL10 region 
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RefSeq genes IL12RB2 MAPKAPK2 MAPKAPK2 a b Figure 3 Fine-mapping of the IL10 and IL23R-IL12RB2 regions. (a,b) Regional association plot and linkage disequilibrium structure of the disease-associated regions surrounding IL10 (a) and IL23R-IL12RB2 (b). SNPs genotyped in the genome-wide analysis (blue) and fine-mapping analysis (green) are shown in the bottom panels. The LD structure of the same regions are shown in the middle panels, with red filled squares linking pairs of markers that indicate the intensity of LD by intensity of fill: D = 1 (intense red) to D = 0 (no fill). In a, the pink circles represent rs1518111 and the yellow circles represent rs3024505, which is associated with inflammatory bowel disease and systemic lupus erythematosus. In b, the pink circles represent rs924080 and the yellow circles represent the IL23R coding variants associated with other seronegative diseases.
l e t t e r s have been shown to be associated with ulcerative colitis 16 , type 1 diabetes 17 , systemic lupus erythematosus 18 and severe juvenile rheumatoid arthritis 12 ; IL-10 receptor mutations were recently shown to cause early onset enterocolitis 19 . Notably, the SNP found in the ulcerative colitis, type 1 diabetes and lupus studies, rs3024505, was not associated with Behçet's disease here (Fig. 3a) , and the Behçet's disease-associated IL10 variants were not associated with these three diseases, suggesting a different IL-10-related disease mechanism in Behçet's disease than in these other diseases. However, the IL10 association with severe juvenile rheumatoid arthritis is the same as for Behçet's disease. Variants from several candidate genes have been examined for association with Behçet's disease. Although no variants within these genes were found with a genome-wide significant association in the Turkish GWAS, 6 of the 12 genes examined contained at least one SNP with nominal significance (P < 0.05; Supplementary  Table 3 ). A much larger sample collection will be required to determine whether any of these genes harbor true Behçet's disease susceptibility alleles.
In summary, we report a GWAS and meta-analysis identifying common variants in IL10 and at the IL23R-IL12RB2 locus that predispose to Behçet's disease. Our study also supports the association of HLA-B*51 as the primary association to Behçet's disease within the MHC region and reveals another independent MHC Class I association telomeric to HLA-B. Expression studies indicate that the disease-associated IL10 variants are associated with decreased expression of this anti-inflammatory cytokine. This may suggest a mechanism, possibly in concert with commensal microorganisms 20 , that results in an inflammation-prone state that increases susceptibility to Behçet's disease. Parentheses in the χ 2 column denote an opposite direction of association.
a Genome-wide significance (P < 5.0 × 10 −8 ). b Breslow-Day Test for homogeneity of the ORs: P = 0.54 for rs1518111, P = 0.71 for rs924080 and P = 0.027 for rs11248047. 
ONLINE METHOdS
Patients and healthy controls. GWAS samples were collected at the Behçet's Disease Clinic of Istanbul Faculty of Medicine, Division of Rheumatology, one of the largest centers for Behçet's disease in Turkey, as consecutive individuals fulfilling the International Study Group Criteria 21 . Demographic and clinical characteristics of the cases are given in Supplementary Table 1 . Healthy controls were selected among blood bank donors or healthy volunteers to match by geographic location the place of birth of the patients (Supplementary  Fig. 1 Whole genome SNP typing, quality control and association analysis. All DNA samples were typed using the Infinium assay (Illumina). The first 332 (146 cases and 186 controls) samples were typed on HumanCNV370-Duo v1.0 chips. The remaining 2,329 samples (1,175 cases and 1,150 controls) were typed on HumanCNV370-Quad v3.0 chips. Samples with high call rates using Illumina-provided HapMap clusters (greater than 99% on Duo chips and greater than 99.5% on Quad chips) were clustered, and these cluster locations were used to determine the genotypes of all the samples. All 2,657 samples (1,321 cases and 1,336 controls) had >95% call rate. SNPs used in the analysis were located on the autosomes, had >95% call rate, >1% minor allele frequency and Hardy Weinberg equilibrium P value > 0.00001, determined separately with Duo and Quad chip data. There were 335,887 autosomal SNPs on the Duo and 334,556 SNPs on the Quad chips. Filtering removed 9,436 SNPs from the Duo and 11,886 SNPs from the Quad chip data. The Duo and Quad data were merged, omitting SNPs not present on both chips (14,970 non-overlapping SNPs from the Duo and 11,188 SNPs from the Quad chips). The merged, autosomal data included 311,482 SNPs. Heterozygosity of X-chromosome SNPs was used to predict the sex of the samples. We removed 19 samples with sex mismatch. PLINK 23 was used to identify samples with genetic relatedness indicating identity (or monozygotic twin) or first, second or third degree relatives. Only one of each pair of identical samples was included; if, however, the identity could not be confirmed, both samples were removed. Only one of each pair of first-to third-degree related samples was included; we selected the sample that was the case or that was the one with the highest call rate. A total of 145 samples were removed for relatedness. The samples used in the genomewide association analysis included 1,215 cases and 1,278 controls. The SNP genotypes from these 2,493 individuals were refiltered using the same criteria (>95% call rate, >1% minor allele frequency and Hardy-Weinberg equilibrium
